CorMedix Inc.
Symbol: CRMD (NASDAQ)
11.62
▼ (-0.13%) -0.015
Company Description:
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.
Key Stats
- Today's Open: $11.6
- Today's High: $11.615
- Today's Low: $11.6
- Today's Volume: 2
- Yesterday Close: $11.63
- Yesterday High: $12.29
- Yesterday Low: $11.61
- Yesterday Volume: 1.92M
- Last Min Volume: 1
- Last Min High: $11.615
- Last Min Low: $11.615
- Last Min VWAP: $11.615
Company Profile
- Name: CorMedix Inc.
- Website: https://www.cormedix.com
- Listed Date: 2010-05-13
- Location: BERKELEY HEIGHTS, NJ
- Market Status: Active
- CIK Number: 0001410098
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $868.17M
- Round Lot: 100
- Outstanding Shares: 74.65M
- Asset Type: CS
RECENT FILINGS FOR CRMD
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-30 | S-3 | View |
| 2025-09-30 | 8-K/A | View |
| 2025-09-18 | 4 | View |
| 2025-09-16 | 4 | View |
| 2025-09-15 | PRE 14A | View |
| 2025-09-12 | 4 | View |
| 2025-09-12 | 4 | View |
| 2025-09-12 | 3 | View |
| 2025-09-12 | SCHEDULE 13D | View |
| 2025-09-12 | 144 | View |
| 2025-09-12 | 144 | View |
| 2025-09-11 | 4 | View |
| 2025-09-11 | 4 | View |
| 2025-09-09 | 144 | View |
| 2025-09-09 | 144 | View |
| 2025-09-08 | 4/A | View |
| 2025-09-08 | 4/A | View |
| 2025-09-03 | 4 | View |
| 2025-09-03 | 4 | View |
| 2025-09-03 | 4 | View |
Latest News on CRMD